Defects in ryanodine receptor function are associated with systolic dysfunction in rats subjected to volume overload

Experimental Physiology

Volumn 95, Issue 8, 2010, Pages 869-879

  Juric, Danijel ^a   Yao, Xinghai ^a   Thandapilly, Sijo ^a   Louis, Xavier ^a   Cantor, Elliott ^a   Chaze, Brian ^a   Wojciechowski, Peter ^a   Vasanji, Zainisha ^a   Yang, Tonghua ^a   Wigle, Jeffrey ^a   Netticadan, Thomas ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE 2A; CELL PROTEIN; PHOSPHOLAMBAN; RYANODINE RECEPTOR; RYANODINE RECEPTOR 2; UNCLASSIFIED DRUG; CALCIUM BINDING PROTEIN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CELL LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLE; ECHOCARDIOGRAPHY; HEART DISEASE; HEART FUNCTION; HEART HYPERTROPHY; HEART VENTRICLE OVERLOAD; HYPOTHESIS; IMMUNOBLOTTING; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; SARCOPLASMIC RETICULUM; SYSTOLE; SYSTOLIC DYSFUNCTION; TISSUE STRUCTURE; WESTERN BLOTTING; ANIMAL; BLOOD VOLUME; CARDIOMEGALY; ECHOGRAPHY; HEART FAILURE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD VOLUME; CALCIUM-BINDING PROTEINS; CARDIOMEGALY; ECHOCARDIOGRAPHY; HEART FAILURE; MALE; RATS; RATS, SPRAGUE-DAWLEY; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SARCOPLASMIC RETICULUM; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; SYSTOLE;

EID: 77954545791     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2009.052100     Document Type: Article

References (40)

1. Babick AP, Cantor EJ, Babick JT, Takeda N, Dhalla NS Netticadan T (2004). Cardiac contractile dysfunction in J2N-k cardiomyopathic hamsters is associated with impaired SR function and regulation. Am J Physiol Cell Physiol 287, C1202 C1208.
2. Benkusky NA, Weber CS, Scherman JA, Farrell EF, Hacker TA, John MC, Powers PA Valdivia HH (2007). Intact β-adrenergic response and unmodified progression toward heart failure in mice with genetic ablation of a major protein kinase A phosphorylation site in the cardiac ryanodine receptor. Circ Res 101, 746 749.
3. Bers DM (2002). Cardiac excitation-contraction coupling. Nature 415, 198 205.
4. Bers DM (2008). Calcium cycling and signaling in cardiac myocytes. Annu Rev Physiol 70, 23 49.
5. Cantor EJ, Babick AP, Vasanji Z, Dhalla NS Netticadan T (2005). A comparative serial echocardiographic analysis of cardiac structure and function in rats subjected to pressure or volume overload. J Mol Cell Cardiol 38, 777 786.
6. Carabello BA (2002). Concentric versus eccentric remodeling. J Card Fail 8, S258 S263.
7. Chelu MG, Danila CI, Gilman CP Hamilton SL (2004). Regulation of ryanodine receptors by FK506 binding proteins. Trends Cardiovasc Med 14, 227 234.
8. Cheng Y, George I, Yi GH, Reiken S, Gu A, Tao YK, Muraskin J, Qin S, He KL, Hay I, Yu K, Oz MC, Burkhoff D, Holmes J Wang J (2007). Bradycardic therapy improves left ventricular function and remodeling in dogs with coronary embolization-induced chronic heart failure. J Pharmacol Exp Ther 321, 469 476. (Pubitemid 46624487)
9. Chohan PK, Singh RB, Dhalla NS Netticadan T (2006). l-Arginine administration recovers sarcoplasmic reticulum function in ischemic reperfused hearts by preventing calpain activation. Cardiovasc Res 69, 152 163.
10. Cox MJ, Sood HS, Hunt MJ, Chandler D, Henegar JR, Aru GM Tyagi SC (2002). Apoptosis in the left ventricle of chronic volume overload causes endocardial endothelial dysfunction in rats. Am J Physiol Heart Circ Physiol 282, H1197 H1205.
11. 2+ homeostasis contributes to myocyte dysfunction during ventricular remodelling induced by chronic volume overload in rats. Clin Exp Pharmacol Physiol 35, 827 835.
12. Frey N, Katus HA, Olson EN Hill JA (2004). Hypertrophy of the heart: a new therapeutic target? Circulation 109, 1580 1589.
13. Garcia R Diebold S (1990). Simple, rapid, and effective method of producing aortocaval shunts in the rat. Cardiovasc Res 24, 430 432.
14. Grossman W, Jones D McLaurin LP (1975). Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 56, 56 64.
15. Hutchinson KR, Majumdar D, Reed RE, Varner KJ, Dell' Italia Lucchesi PA (2007). Chronic volume overload induces an anti-fibrotic cardiac fibroblast phenotype in rat hearts. FASEB J 21, 908 931.
16. Hisamatsu Y, Ohkusa T, Kihara Y, Inoko M, Ueyama T, Yano M, Sasayama S Matsuzaki M (1997). Early changes in the functions of cardiac sarcoplasmic reticulum in volume-overloaded cardiac hypertrophy in rats. J Mol Cell Cardiol 29, 1097 1109. (Pubitemid 27211891)
17. Janicki JS, Brower GL, Gardner JD, Forman MF, Stewart JA Jr., Murray DB Chancey AL (2006). Cardiac mast cell regulation of matrix metalloproteinase- related ventricular remodeling in chronic pressure or volume overload. Cardiovasc Res 69, 657 665.
18. Katz AM Lorell BH (2000). Regulation of cardiac contraction and relaxation. Circulation 102, IV69 IV74.
19. Latronico MV, Elia L, Condorelli G Catalucci D (2008). Heart failure: targeting transcriptional and post-transcriptional control mechanisms of hypertrophy for treatment. Int J Biochem Cell Biol 40, 1643 1648.
20. Lowry OH, Rosebrough NJ, Farr AL Randall RJ (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193, 265 275.
21. MacDonnell SM, García-Rivas G, Scherman JA, Kubo H, Chen X, Valdivia H Houser SR (2008). Adrenergic regulation of cardiac contractility does not involve phosphorylation of the cardiac ryanodine receptor at serine 2808. Circ Res 102, e65 e72.
22. MacDougall LK, Jones LR Cohen P (1991). Identification of the major protein phosphatases in mammalian cardiac muscle which dephosphorylate phospholamban. Eur J Biochem 196, 725 734.
23. MacLennan DH Kranias EG (2003). Phospholamban: a crucial regulator of cardiac contractility. Nat Rev Mol Cell Biol 4, 566 577.
24. Matsubara LS, Narikawa S, Ferreira AL, Paiva SA, Zornoff LM Matsubara BB (2006). Myocardial remodeling in chronic pressure or volume overload in the rat heart. [Article in Portuguese] Arq Bras Cardiol 86, 126 130.
25. Meissner G (2004). Molecular regulation of cardiac ryanodine receptor ion channel. Cell Calcium 35, 621 628.
26. Mudd JO Kass DA (2008). Tackling heart failure in the twenty-first century. Nature 451, 919 928.
27. Nediani C, Formigli L, Perna AM, Pacini A, Ponziani V, Modesti PA, Ibba-Manneschi L, Zecchi-Orlandini S, Fiorillo C, Cecchi C, Liguori P, Fratini G, Vanni S Nassi P (2002). Biochemical changes and their relationship with morphological and functional findings in pig heart subjected to lasting volume overload: a possible role of acylphosphatase in the regulation of sarcoplasmic reticulum calcium pump. Basic Res Cardiol 97, 469 478.
28. O'Brien PJ, Moe GW, Nowack LM, Grima EA Armstrong PW (1994). Sarcoplasmic reticulum Ca-release channel and ATP-synthesis activities are early myocardial markers of heart failure produced by rapid ventricular pacing in dogs. Can J Physiol Pharmacol 72, 999 1006.
29. Ochi R Gupte SA (2007). Ryanodine receptor: a novel therapeutic target in heart disease. Recent Pat Cardiovasc Drug Discov 2, 110 118.
30. Oda T, Yano M, Yamamoto T, Tokuhisa T, Okuda S, Doi M, Ohkusa T, Ikeda Y, Kobayashi S, Ikemoto N Matsuzaki M (2005). Defective regulation of interdomain interactions within the ryanodine receptor plays a key role in the pathogenesis of heart failure. Circulation 111, 3400 3410. (Pubitemid 40923393)
31. Opie LH, Commerford PJ, Gersh BJ Pfeffer MA (2006). Controversies in ventricular remodelling. Lancet 367, 356 367.
32. 2+ leak from the sarcoplasmic reticulum and increases contractility. Circ Res 88, 188 194.
33. Ryan TD, Rothstein EC, Aban I, Tallaj JA, Husain A, Lucchesi PA Dell'Italia LJ (2007). Left ventricular eccentric remodeling and matrix loss are mediated by bradykinin and precede cardiomyocyte elongation in rats with volume overload. J Am Coll Cardiol 49, 811 821.
34. Schmidt U, Hajjar RJ, Helm PA, Kim CS, Doye AA Gwathmey JK (1998). Contribution of abnormal sarcoplasmic reticulum ATPase activity to systolic and diastolic dysfunction in human heart failure. J Mol Cell Cardiol 30, 1929 1937.
35. Selvetella G, Hirsch E, Notte A, Tarone G Lembo G (2004). Adaptive and maladaptive hypertrophic pathways: points of convergence and divergence. Cardiovasc Res 63, 373 380.
36. Singh RB, Chohan PK, Dhalla NS Netticadan T (2004). The sarcoplasmic reticulum proteins are targets for calpain action in the ischemic-reperfused heart. J Mol Cell Cardiol 37, 101 110.
37. Vasanji Z, Cantor EJ, Juric D, Moyen M Netticadan T (2006). Alterations in cardiac contractile performance and sarcoplasmic reticulum function in sucrose-fed rats is associated with insulin resistance. Am J Physiol Cell Physiol 291, C772 C780.
38. Wang X, Ren B, Liu S, Sentex E, Tappia PS Dhalla NS (2003). Characterization of cardiac hypertrophy and heart failure due to volume overload in the rat. J Appl Physiol 94, 752 763.
39. Wehrens XH, Lehnart SE, Reiken S, Vest JA, Wronska A Marks AR (2006). Ryanodine receptor/calcium release channel PKA phosphorylation: a critical mediator of heart failure progression. Proc Natl Acad Sci U S A 103, 511 518.
40. Yamaguchi F, Sanbe A Takeo S (1997). Cardiac sarcoplasmic reticular function in rats with chronic heart failure following myocardial infarction. J Mol Cell Cardiol 29, 753 763. (Pubitemid 27192881)